News

NBIX

AbbVie Announces Positive Results from Second Phase 3 Uterine Fibroids Study

Edward Kim | Equities.com |

Results were consistent with the first Phase 3 study, demonstrating reduction in heavy menstrual bleeding compared to placebo.


Neurocrine Biosciences Plummets on Drug Trial Failure

Jacob Harper | Equities.com |

Neurocrine Biosciences Inc (NBIX) experienced a significant setback on Sept. 8 when the company revealed a lower dose of a drug designed to treat a rare involuntary muscle movement disorder had


Equities Sector Coverage: Stocks Close Higher on Jobs

Sector Recap | Equities.com |

Initial Jobless Claims rose to 367,000 staying above the 350,000 recessionary threshold. Factory Orders fell 5.2% in August the biggest drop since January 2009. Freddie Mac set its 30-year fixed


Equities Sector Coverage: Stocks Fade in Late Trading to End Lower

Sector Recap | Equities.com |

The S&P/Case-Shiller 20-city composite index of home prices showed a decline of 0.8% in January, a slightly bigger decline than expected. Home prices were down 3.8% year over year. The


Equities Sector Coverage: Wall Street Trades Flat to Close Strong Week

Sector Recap | Equities.com |

CPI rose 0.4% in February as gasoline prices rose 6.0% the highest amount since December 2010. CPI was up 2.9% year over year. Excluding food & energy CPI rose just 0.1%. Industrial Production


Equities Sector Coverage: Investor Optimism Returns to Wall Street

Sector Recap | Equities.com |

Initial Jobless Claims for the week ending March 3 was 362,000, an increase of 8,000 from the previous week's revised figure of 354,000. The Dow Jones Industrial Average rallied to an afternoon


Sponsored Financial Content

Market Movers